Abstract Background A total of 44.7% adults in China have hypertension, but the prevalence
of primary aldosteronism (PA) in Chinese hypertensive patients is unknown. Objectives This …

Objectives: It is estimated that there are more than 16 million adults with drug-resistant
hypertension in China. Nevertheless, the prevalence of and risk factors for primary …

Objectives: We prospectively investigated the prevalence of curable forms of primary
aldosteronism (PA) in newly diagnosed hypertensive patients. Background: The prevalence …

Primary aldosteronism (PA) was first reported by Jerome W. Conn in 1954 when it was
considered a rare disorder, only suspected in cases of hypertension and spontaneous …

Background/Purpose Even though the increasing clinical recognition of primary
aldosteronism (PA) as a public health issue, its heightened risk profiles and the availability …

Recent studies using the ratio of plasma aldosterone concentration (PAC) to PRA as the
screening test for primary aldosteronism in hypertensive populations suggested that the …

Background: Despite being widely recognized as the most common form of secondary
hypertension, among the general hypertensive population the true prevalence of primary …

There is an ongoing controversy on the prevalence of primary aldosteronism (PA). We
aimed to update a meta-analysis published in 2008, that compiled studies reporting the …

Primary aldosteronism (PA) has been considered a rare cause of hypertension. The
introduction of the aldosterone/renin ratio (ARR) as a screening test has led to an increase …

We studied 1,020 patients with hypertension visiting our outpatient clinic during a five-year
period, from 1995 until 1999. Those subjects were screened by determining plasma renin …